Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
Learn more about our ranking as a top pediatric hospital here.
The Deaf and Hard of Hearing Program at Boston Children's Hospital provides comprehensive evaluation and consultative services to deaf and hard of hearing children. We'll also interact closely with your child's physician, schools, and any other applicable agencies.
Our team at the Deaf and Hard of Hearing Program cares for more than 1,000 children and their families each year, including children and adolescents with known or previously diagnosed hearing loss.
Our program is one of the largest and most experienced programs of its kind in the country.
Services we Specialize in:
American Sign Language
Deafness and Hearing Loss
cognitive and psycho-educational assessments
functional communication and interaction assessments
speech, spoken language and auditory skills assessments
sign language assessments
serves as a resource center, providing referral for services and/or to agencies and organizations
disseminates information regarding assistive devices, educational approaches, specialized materials, etc.
provides short term speech-language therapy, individual counseling and parent guidance
conducts baseline mental health assessments of deaf or hard of hearing youngsters
The Department of Otolaryngology conducts both basic research and clinical studies of hearing. Gabriel Corfas, PhD, is the director of basic science research in Otolaryngology. His laboratory investigates the mechanisms that contribute to loss of hearing and balance with the aim of developing tools to treat these disorders. Using genetically modified mice, the Corfas laboratory has identified new cellular and molecular mechanisms that underlie degeneration of the inner ear.
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”